Abstract
Prostacyclin (PGI2) inhibits platelet aggregation and vasoconstriction. PGI2 synthase (PGIS), a catalyst of PGI2 formation from prostaglandin H2, is widely distributed and predominantly found in vascular endothelial and smooth muscle cells. Vane et al. first discovered PGI2 in 1976, for which they received the Nobel Prize in medicine and physiology in 1982. However, the later discovery of nitric oxide (NO), which also resulted in a Nobel Prize for the scientists involved, led to less attention being focused on PGI2. The reason for this is somewhat perplexing and may have been due to the lack of information on how to correctly use PGI2. Current findings suggest that researchers concentrated too much effort on the therapeutic effects of PGI2, while largely ignoring the potential for preventative effects. In addition, PGI2 was shown to be effective against diseases in some studies but was without effect in others. The present paper contains a review of PGI2 and PGIS, in addition to an examination of the relationship between PGIS gene mutations and cardiovascular diseases. PGI2 analogues that can be used in the prevention of cardiovascular diseases are also discussed.
Keywords: Prostacyclin, association study, prevention, cardiovascular diseases, mutation, polymorphism
Cardiovascular & Hematological Agents in Medicinal Chemistry
Title: Prostacyclin Analogues: Prevention of Cardiovascular Diseases
Volume: 4 Issue: 4
Author(s): Tomohiro Nakayama
Affiliation:
Keywords: Prostacyclin, association study, prevention, cardiovascular diseases, mutation, polymorphism
Abstract: Prostacyclin (PGI2) inhibits platelet aggregation and vasoconstriction. PGI2 synthase (PGIS), a catalyst of PGI2 formation from prostaglandin H2, is widely distributed and predominantly found in vascular endothelial and smooth muscle cells. Vane et al. first discovered PGI2 in 1976, for which they received the Nobel Prize in medicine and physiology in 1982. However, the later discovery of nitric oxide (NO), which also resulted in a Nobel Prize for the scientists involved, led to less attention being focused on PGI2. The reason for this is somewhat perplexing and may have been due to the lack of information on how to correctly use PGI2. Current findings suggest that researchers concentrated too much effort on the therapeutic effects of PGI2, while largely ignoring the potential for preventative effects. In addition, PGI2 was shown to be effective against diseases in some studies but was without effect in others. The present paper contains a review of PGI2 and PGIS, in addition to an examination of the relationship between PGIS gene mutations and cardiovascular diseases. PGI2 analogues that can be used in the prevention of cardiovascular diseases are also discussed.
Export Options
About this article
Cite this article as:
Nakayama Tomohiro, Prostacyclin Analogues: Prevention of Cardiovascular Diseases, Cardiovascular & Hematological Agents in Medicinal Chemistry 2006; 4 (4) . https://dx.doi.org/10.2174/187152506784111463
DOI https://dx.doi.org/10.2174/187152506784111463 |
Print ISSN 1871-5257 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6182 |
Call for Papers in Thematic Issues
Medicinal Plants with Beneficial Properties on Diabetes and Hypertension
Diabetes and hypertension are real scourges of the 21st century. It is imperative to act in order to find innovative solutions to this problem. Taking medications such as hypoglycemic and antihypertensive drugs may aggravate certain underlying comorbidities, such as chronic kidney disease and cardiovascular disease. This significant drawback therefore requires ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Predictors of Cardiovascular Affection in Patients with Active Rheumatoid Arthritis: Secondary Analysis of a Randomized Controlled Trial
Current Rheumatology Reviews Pyrazolines: A Biological Review
Mini-Reviews in Medicinal Chemistry Role and Services of a Pharmacist in the Prevention of Medication Errors: A Systematic Review
Current Drug Safety Combination Therapy of Statins with Ezetimibe
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Angiotensin II Receptor Blocker: Possibility of Antitumor Agent for Prostate Cancer
Mini-Reviews in Medicinal Chemistry Obesity and Inflammation – Targets for OA Therapy
Current Drug Targets Cellular Cardiomyoplasty and Cardiac Regeneration
Current Cardiology Reviews Long-Term Outcome of Cardio Respiratory Exercise Performance After Surgery
Current Respiratory Medicine Reviews Effect of Fenofibrate on the Concentration and Relative Distribution of LDL Subfractions in Patients with Combined Dyslipidemia
Letters in Drug Design & Discovery The Right Ventricle: Biologic Insights and Response to Disease
Current Cardiology Reviews Melatonin Effects in REM Sleep Behavior Disorder Associated with Obstructive Sleep Apnea Syndrome: A Case Series
Current Alzheimer Research Life-Threatening Respiratory Syncytial Virus Disease in Children
Current Respiratory Medicine Reviews Homocysteine, Cardiovascular Inflammation, and Myocardial Remodeling
Cardiovascular & Hematological Disorders-Drug Targets Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults
Current Medicinal Chemistry The Nature of Immunological Reaction in the Peripheral Airways of Cigarette Smokers
Current Respiratory Medicine Reviews Multifaceted Individualities in Pharmacological Treatments of Obesity
Current Clinical Pharmacology Nocturnal Hypertension, Nondipping Phenomenon and Target Organ Damage in Obstructive Sleep Apnea Patients - The Bad and the Worse
Current Respiratory Medicine Reviews GRK2 and Beta-Arrestins in Cardiovascular Disease: Established and Emerging Possibilities for Therapeutic Targeting
Current Molecular Pharmacology Heart Failure Models: Traditional and Novel Therapy
Current Vascular Pharmacology A Review of the English and Russian Language Literature on the Osteoarticular Manifestations of Brucellosis Infection
Current Rheumatology Reviews